The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
 
 
Consulting or Advisory Role - AstraZeneca; BeiGene; Takeda
Research Funding - Acerta Pharma/AstraZeneca (Inst); Ayala Pharmaceuticals (I); Bayer (Inst); BeiGene (Inst); Bristol-Myers Squibb (I); De Novo Pharmaceuticals (Inst); Genentech/Roche (Inst); Ignyta (I); Incyte (Inst); Merck Sharp & Dohme (Inst); Pharmacyclics (Inst); Portola Pharmaceuticals (Inst); Seagen (Inst)
Trial in progress: A phase III, randomized, open-label study comparing zanubrutinib plus rituximab versus bendamustine plus rituximab in patients with previously untreated mantle cell lymphoma (MCL).
 
Martin H. Dreyling
Consulting or Advisory Role - Acerta Pharma/AstraZeneca; Bayer/Vital; Celgene/Jazz; Gilead Sciences; Janssen-Cilag; Novartis; Roche; Sandoz-Novartis
Speakers' Bureau - Bayer Health; Celgene; Gilead Sciences; Janssen-Cilag; Roche Pharma AG
Research Funding - Celgene (Inst); Janssen-Cilag (Inst); Mundipharma (Inst); Roche Pharma AG (Inst)
Travel, Accommodations, Expenses - Celgene; Janssen-Cilag; Roche Pharma AG
 
Constantine Si Lun Tam
Honoraria - Abbvie; Beigene; Janssen-Cilag; Novartis; Pharmacyclics
Consulting or Advisory Role - Abbvie; BeiGene; Janssen; Loxo; Roche
Research Funding - Abbvie (Inst); Janssen-Cilag (Inst)
 
Michael Wang
Stock and Other Ownership Interests - More Health
Honoraria - AstraZeneca; Dava Oncology; Janssen Research & Development; OM Pharmaceutical Industries; Onclive; oncology business review; Peerview; Pharmacyclics; Targeted Oncology
Consulting or Advisory Role - AstraZeneca; AxImmune; Bioinvent; Celgene; Guidepoint Global; Janssen Research & Development; Juno Therapeutics; Kite, a Gilead company; Loxo; More Health; Noble Insights; Pharmacyclics/Janssen; Pulse Biosciences
Research Funding - Acerta Pharma; Amgen; AstraZeneca; BeiGene; Bioinvent; Celgene; Janssen Research & Development; Juno Therapeutics; Kite, a Gilead company; Loxo; Novartis; Oncternal Therapeutics; Pharmacyclics; VelosBio; Verastem
Travel, Accommodations, Expenses - AstraZeneca; Celgene; Dava Oncology; Janssen Research & Development; OM Pharmaceutical Industries
 
Stephen Douglas Smith
No Relationships to Disclose
 
Marco Ladetto
Honoraria - Abbvie; Acerta Pharma; ADC Therapeutics; Amgen; Archigen Biotech; BeiGene; Celgene; Gilead Sciences; Johnson & Johnson; Novartis; Roche; Roche; Sandoz; Takeda
Consulting or Advisory Role - Abbvie; Acerta Pharma; ADC Therapeutics; Amgen; Archigen Biotech; BeiGene; Celgene; Gilead Sciences; Johnson & Johnson; Novartis; Roche; Roche; Sandoz; Takeda
Research Funding - Abbvie; Abbvie (Inst); Acerta Pharma; Acerta Pharma (Inst); ADC Therapeutics; ADC Therapeutics (Inst); Amgen; Amgen (Inst); Archigen Biotech; Archigen Biotech (Inst); BeiGene; BeiGene (Inst); Celgene; Celgene (Inst); Gilead Sciences; Gilead Sciences (Inst); Johnson & Johnson; Johnson & Johnson (Inst); Novartis; Novartis (Inst); Roche; Roche; Roche (Inst); Roche (Inst); Sandoz; Sandoz (Inst); Takeda; Takeda (Inst)
Travel, Accommodations, Expenses - Abbvie; Acerta Pharma; ADC Therapeutics; Amgen; Archigen Biotech; BeiGene; Celgene; Gilead Sciences; Johnson & Johnson; Novartis; Roche; Roche; Sandoz; Takeda
 
Huiqiang Huang
No Relationships to Disclose
 
Rebecca L. Elstrom
Employment - BeiGene
Stock and Other Ownership Interests - BeiGene; Roche
 
Melannie Co
Employment - BeiGene
Stock and Other Ownership Interests - BeiGene
Travel, Accommodations, Expenses - BeiGene
 
Eric Holmgren
Employment - BeiGene
Stock and Other Ownership Interests - BeiGene
 
Jane Huang
Employment - BeiGene
Leadership - BeiGene
Stock and Other Ownership Interests - BeiGene
 
Steven Le Gouill
Honoraria - Roche/Genentech
Consulting or Advisory Role - Roche/Genentech
Research Funding - Roche/Genentech
Travel, Accommodations, Expenses - Roche/Genentech